TrialSpark Stock

trialspark.comHealthcareFounded: 2013Funding to Date: $246.91MM

TrialSpark is a technology company focused on accelerating the pace of clinical trials to bridge the gap between medical research and patients who need treatment.

Register for Details

For more details on financing and valuation for TrialSpark, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for TrialSpark.

Register Today

Team

Management Team

Kit Dobyns
Co-Founder
Benjamine Liu Ph.D
Co-Founder & Chief Executive Officer
Linhao Zhang
Co-Founder

Other companies like TrialSpark in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- 23andMe, the leading consumer genetics company, and TrialSpark, a technology company enabling physician practices to...
The partners announced that they are putting out a request for clinical trial proposals in the areas of dermatology, gastroenterology, pulmonology, endocrinology, ophthalmology, inflammatory diseases, neurology, women’s health and rare diseases.